Women with harmful mutations in either BRCA1 or BRCA2 have a risk of breast cancer that is about five times the normal risk, and a risk of ovarian cancer which is about ten to thirty times the normal risk [4]. The gene discussed is BRCA2; the disease is breast carcinoma.